Research Progress on Lung Cancer Screening.
10.3779/j.issn.1009-3419.2020.101.37
- Author:
Yazhe GUAN
1
;
Meng REN
1
;
Dongli GUO
1
;
Yutong HE
1
Author Information
1. Cancer Institute, Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China.
- Publication Type:Journal Article
- Keywords:
Cost-effectiveness;
Lung neoplasms;
Screening
- From:
Chinese Journal of Lung Cancer
2020;23(11):954-960
- CountryChina
- Language:Chinese
-
Abstract:
Lung cancer is the most common malignant tumor in the world. The five-year survival rate is 19.7%, which seriously threatens human health. Lung cancer screening is an effective measure to reduce lung cancer mortality. Existing studies have shown that screening with low-dose computed tomography (LDCT) can reduce lung cancer deaths by 20%. Currently, lung cancer screening is recommended internationally and nationally. Studying the development status of lung cancer screening helps us to identify the high-risk groups of lung cancer, explore reasonable screening programs, improve the cost-effectiveness of screening and reduce the economic burden. Therefore, this article summarizes the current status of lung cancer screening, the cost-effectiveness of lung cancer screening and the existing problems as follows.
.
